NuGen Medical Devices

NuGen Medical Devices is a specialty medical device company based in Toronto, Ontario, Canada. The company focuses on developing and commercializing innovative needle-free drug delivery technologies aimed at improving the administration of subcutaneous medications. Their mission is to provide safer and more comfortable alternatives to traditional needle injections, benefiting millions of patients globally by reducing the pain and anxiety associated with needles. The flagship product is the InsuJet™, a needle-free injection device designed for diabetic patients to administer insulin without needles. The InsuJet family includes several models, ensuring safe and effective medication delivery. NuGen also offers a diabetic lifestyle subscription service, allowing direct-to-consumer sales of the InsuJet device and consumables. Their products serve a wide range of customers, including healthcare providers and veterinary professionals, and are marketed internationally across Europe, Asia, North America, and Mexico. The company is publicly traded under the ticker NGMDF and continues to expand its market presence and regulatory approvals.

• Employees 1
• Founded 2017
• Annual Revenue $702000
• Total Funding $14441800